Last edition
News about "active pharmaceutical ingredients (APIs)"
Aurobindo Pharma Expands Business in Malaysia with New Subsidiary
Aurobindo Pharma has announced the incorporation of a new wholly owned subsidiary, Aurobindo Pharma (Malaysia) SDN. BHD., through its subsidiary Helix Healthcare B.V.
Active Pharmaceutical Ingredients (APIs) | 18/09/2025 | By Dineshwori
FDA Launches 'Green List' to Crack Down on Illegal GLP-1 API Imports
The US Food and Drug Administration (FDA) has created a new “green list” import alert to stop potentially dangerous GLP-1 (glucagon-like peptide-1) active pharmaceutical ingredients (APIs) from unverified foreign sources from entering the US market.
Active Pharmaceutical Ingredients (APIs) | 09/09/2025 | By Dineshwori | 146
India's Push for API Self-Reliance Under the PLI Scheme
India’s Production Linked Incentive (PLI) scheme for bulk drugs and key starting materials is transforming the country’s pharmaceutical manufacturing landscape, pushing the sector toward self-reliance.
Active Pharmaceutical Ingredients (APIs) | 31/08/2025 | By Darshana | 290
Senores Pharmaceuticals Appoints Manohar Lalge as President - Research & Development
Senores Pharmaceuticals Ltd. (SPL) has appointed Manohar Lalge as President – Research and Development.
Active Pharmaceutical Ingredients (APIs) | 20/08/2025 | By Dineshwori
FDA Launches PreCheck Program to Boost US Drug Manufacturing
The US Food and Drug Administration (USFDA) has unveiled a new program aimed at strengthening the domestic pharmaceutical supply chain by increasing regulatory predictability and facilitating the construction of manufacturing sites in the United States.
Active Pharmaceutical Ingredients (APIs). | 11/08/2025 | By Dineshwori
FDA Launches PreCheck Program to Boost US Drug Manufacturing
The US Food and Drug Administration (USFDA) has unveiled a new program aimed at strengthening the domestic pharmaceutical supply chain by increasing regulatory predictability and facilitating the construction of manufacturing sites in the United States.
Active Pharmaceutical Ingredients (APIs) | 11/08/2025 | By Dineshwori
Governor of New York State Kathy Hochul has announced that Garonit Pharmaceutical, a global manufacturer of antiseptic products and health care solutions, will establish a state-of-the-art, 200,000-square-foot pharmaceutical manufacturing facility in New Windsor, Orange County.
Active Pharmaceutical Ingredients (APIs) | 05/08/2025 | By Dineshwori | 106
Torrent Pharma Seeks CCI Nod for INR 19,500 Crore Acquisition of JB Chemicals
According to the filing, the transaction involves acquisition of shares in JB Chemicals, followed by the amalgamation of the target company with Torrent Pharmaceuticals.
Active Pharmaceutical Ingredients (APIs) | 18/07/2025 | By Darshana | 117
Centrient Pharmaceuticals Appoints New Site Director for Delft Facility
Centrient Pharmaceuticals has announced the appointment of Pierre-Yves Dalla-Libera as the new Site Director for its Delft facility, effective September 1, 2025.
Active Pharmaceutical Ingredients (APIs) | 10/07/2025 | By Dineshwori | 239
Covid-19: Pharma companies ask Govt to lift API's export restrictions
Pharmaceutical lobby groups have urged the government to lift restrictions on export of active pharmaceutical ingredients (APIs) and formulations, saying they have enough stock and there will be no shortage of these formulations in India amid the coronavirus outbreak
Active Pharmaceutical Ingredients (APIs) | 12/03/2020 | By Darshana | 405
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy